Published in:
01-12-2020 | Acute Kidney Injury | Letter
Biomarkers to delineate bacteremia from candidemia remain a challenging issue
Authors:
Patrick M. Honore, Christina David, Rachid Attou, Sebastien Redant, Andrea Gallerani, David De Bels
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
In their recent systematic review, Cortegiani et al. found that serum procalcitonin (PCT) concentrations were higher in patients with bacteremia as compared to candidemia [
1]. Quality of data was poor and did not allow to use PCT alone to differentiate bacteremia from candidemia [
1]. While we agree with their findings regarding patients with positive hemocultures in the ward, we would like to address the results of the patients with positive hemocultures in the intensive care unit (ICU) [
1]. In a randomized controlled study (RCT) comparing the clinical manifestations of septic shock caused by bacteria or
Candida spp., the rate of acute kidney injury (AKI) defined by a creatinine above 3.5 mg/dl or the need of any form of renal replacement therapy (RRT) was around 20% in the bacteria group versus above 40% in the candida group, while having similar Acute Physiology and Chronic Health Evaluation (APACHE) II scores [
2]. Accordingly, the rate of RRT in the candidemia group will be twice as high as compared to the bacteremia group [
2]. It is plausible that there are similar trends in the Cortegiani study [
2]. PCT has an approximate molecular weight of 14.5 kDa [
3]. The contemporary continuous RRT (CRRT) membranes are able to remove molecules as large as 35 kDa [
3]. Hence, most of the PCT mass will be eliminated by convective flow [
3], but adsorption also contributes to elimination if using new highly adsorptive membranes (HAM) [
4]. Accordingly, imbalance between the use of CRRT in the two cohorts (bacteremia versus candidemia) will have an important impact upon the values of PCT in each cohort. PCT levels may therefore be affected not only by the type of pathogen but also by the incidence of RRT. A future study with a focus on the performance of the currently known sepsis biomarkers among those who receive CRRT is urgently needed [
4]. As alluded too by Cortegiani et al., beta-
d-glucan (BDG) could be a very good candidate associated to PCT. Indeed, BDG could be even a better candidate as its molecular weight ranges from several hundred thousand to 10 million daltons and does not pass through any membrane [
4,
5]. Finally, we would like to add that BDG can be also be falsely elevated in case of gastrointestinal colonization of
Candida albicans that increases serum BDG without candidemia [
5]. …